Alaunos Therapeutics, Inc. short interest in 2021
In 2021, Alaunos Therapeutics, Inc.'s disclosed short interest ran from 15.20% of shares outstanding on 15 Jan 2021 to 15.75% on 31 Dec 2021, a change of +0.55 percentage points. The year's high was 18.38% on 31 Mar 2021 and its low 14.90% on 15 Oct 2021, averaging 16.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.57 days on 28 May 2021. Full history: Alaunos Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 15.20% (15 Jan 2021)
- End of year
- 15.75% (31 Dec 2021)
- Change
- +0.55 pp
- High
- 18.38% (31 Mar 2021)
- Low
- 14.90% (15 Oct 2021)
- Average
- 16.32%
- Highest days to cover
- 34.57 (28 May 2021)
- SEC filings marked
- 7
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 15.20% | 13.80 | |
| 29 Jan 2021 | 14.97% | 10.18 | |
| 12 Feb 2021 | 15.84% | 9.53 | |
| 26 Feb 2021 | 16.42% | 16.91 | results (8-K) |
| 15 Mar 2021 | 16.51% | 13.10 | 10-K filed |
| 31 Mar 2021 | 18.38% | 17.60 | |
| 15 Apr 2021 | 18.21% | 32.78 | |
| 30 Apr 2021 | 18.27% | 33.29 | |
| 14 May 2021 | 17.98% | 25.67 | 10-Q filed, results (8-K) |
| 28 May 2021 | 17.33% | 34.57 | |
| 15 Jun 2021 | 17.31% | 15.13 | |
| 30 Jun 2021 | 16.34% | 16.06 | |
| 15 Jul 2021 | 16.55% | 29.28 | |
| 30 Jul 2021 | 16.92% | 28.06 | |
| 13 Aug 2021 | 16.40% | 18.14 | results (8-K), 10-Q filed |
| 31 Aug 2021 | 15.90% | 15.13 | |
| 15 Sep 2021 | 15.77% | 3.32 | |
| 30 Sep 2021 | 15.06% | 11.63 | |
| 15 Oct 2021 | 14.90% | 17.90 | |
| 29 Oct 2021 | 15.15% | 18.28 | |
| 15 Nov 2021 | 15.14% | 19.85 | 10-Q filed |
| 30 Nov 2021 | 15.38% | 13.56 | |
| 15 Dec 2021 | 15.97% | 12.46 | |
| 31 Dec 2021 | 15.75% | 12.59 |
See also: Alaunos Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.